loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 202192 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 INCYTE CORP (5)

filter

01 TABLET;ORAL (5)

filter

01 RX (5)

filter

01 JAKAFI (5)

filter

01 Yes (5)

URL Supplier Web Content
TABLET; ORAL
EQ 10MG BASE
2011-11-16
202192
JAKAFI
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 25MG BASE
2011-11-16
202192
JAKAFI
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 15MG BASE
2011-11-16
202192
JAKAFI
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 5MG BASE
2011-11-16
202192
JAKAFI
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 20MG BASE
2011-11-16
202192
JAKAFI
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202192

Looking for FDA Orange Book APPLICATION 202192 5

19

Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.

Regulatory Information RX

With a dosage strength EQ 10MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-11-16

18

Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.

Regulatory Information RX

With a dosage strength EQ 25MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-11-16

17

Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.

Regulatory Information RX

With a dosage strength EQ 15MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-11-16

16

Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.

Regulatory Information RX

With a dosage strength EQ 5MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-11-16

15

Incyte Corporation, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUXOLITINIB PHOSPHATE, with a corresponding application number 202192.

Regulatory Information RX

With a dosage strength EQ 20MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2011-11-16

Post Enquiry
POST ENQUIRY